| Species | C. briggsae |
| Raw Lifespan Data | 18 compounds tested / 9 datasets |
| Summary Statistics | 20 tests from Cox Proportional Hazards analysis |
| Survival | 22 Kaplan-Meier plots |
| Strain Description | WBStrain00041077 |
CITP Publications
Banse et al. (2025). Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse Caenorhabditis nematodes. eLife.
DOI:10.7554/eLife.104375
PMID:41432067
Banse et al. (2024). Antioxidants green tea extract and nordihydroguaiaretic acid confer species and strain-specific lifespan and health effects in Caenorhabditis nematodes. GeroScience.
DOI:10.1007/s11357-023-00978-0
PMID:37923874
Onken et al. (2021). Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes. Aging Cell.
DOI:10.1111/acel.13488
PMID:34837316
Banse et al. (2019). Automated lifespan determination across Caenorhabditis strains and species reveals assay-specific effects of chemical interventions. GeroScience.
DOI:10.1007/s11357-019-00108-9
PMID:31820364
Lucanic et al. (2017). Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects. Nature Communications.
DOI:10.1038/ncomms14256
PMID:28220799
Morshead et al. (2020). Caenorhabditis Intervention Testing Program: the farnesoid X receptor agonist obeticholic acid does not robustly extend lifespan in nematodes. microPublication Biology.
DOI:10.17912/micropub.biology.000257
PMID:32550518